NEW YORK (GenomeWeb) – Finnish molecular diagnostics firm Mobidiag today announced that its Amplidiag qPCR-based stool test for detection of Helicobacter pylori and clarithromycin resistance has received CE-IVD marking.

The test, part of the firm's Amplidiag line of gastric pathogen tests, will be immediately available throughout Europe.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.